A hefty stock float for local biotech Orexigen gives it an additional $70M to develop its experimental obesity drug.
http://www.xconomy.com/san-diego/2009/07/23/orexigen-raises-70m/A hefty stock float for local biotech Orexigen gives it an additional $70M to develop its experimental obesity drug.
http://www.xconomy.com/san-diego/2009/07/23/orexigen-raises-70m/Posted in Uncategorized
